{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T06:50:05Z","timestamp":1772261405708,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1124\/jpet.114.218768","type":"journal-article","created":{"date-parts":[[2014,10,18]],"date-time":"2014-10-18T04:18:53Z","timestamp":1413605933000},"page":"43-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Seizure Control by Derivatives of Medium Chain Fatty Acids Associated with the Ketogenic Diet Show Novel Branching-Point Structure for Enhanced Potency"],"prefix":"10.1016","volume":"352","author":[{"given":"Pishan","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra M.E.","family":"Zuckermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam J.","family":"Close","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marife","family":"Cano-Jaimez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"McEvoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew C.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin S.B.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.114.218768_bib1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1517\/14740338.4.2.345","article-title":"Teratogenicity of sodium valproate","volume":"4","author":"Alsdorf","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1124\/jpet.114.218768_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2000"},{"key":"10.1124\/jpet.114.218768_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0920-1211(98)00030-8","article-title":"Effects of new valproate derivatives on epileptiform discharges induced by pentylenetetrazole or low Mg2+ in rat entorhinal cortex-hippocampus slices","volume":"32","author":"Armand","year":"1998","journal-title":"Epilepsy Res"},{"key":"10.1124\/jpet.114.218768_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(01)00302-3","article-title":"Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy","volume":"47","author":"Barton","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1124\/jpet.114.218768_bib5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1053\/seiz.2001.0584","article-title":"The epidemiology of epilepsy: the size of the problem","volume":"10","author":"Bell","year":"2001","journal-title":"Seizure"},{"key":"10.1124\/jpet.114.218768_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.eplepsyres.2010.09.001","article-title":"Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X)","volume":"92","author":"Bialer","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1124\/jpet.114.218768_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrd2997","article-title":"Key factors in the discovery and development of new antiepileptic drugs","volume":"9","author":"Bialer","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.114.218768_bib8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.nurt.2006.11.007","article-title":"Valproic acid: second generation","volume":"4","author":"Bialer","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1124\/jpet.114.218768_bib9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0306-4522(03)00027-7","article-title":"N-methyl-d-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy","volume":"118","author":"Brandt","year":"2003","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.114.218768_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1242\/dmm.008029","article-title":"The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in Dictyostelium","volume":"5","author":"Chang","year":"2012","journal-title":"Dis Model Mech"},{"key":"10.1124\/jpet.114.218768_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuropharm.2012.11.004","article-title":"Seizure control by ketogenic diet-associated medium chain fatty acids","volume":"69","author":"Chang","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.114.218768_bib12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.eplepsyres.2010.11.006","article-title":"Valproate decreases frequency facilitation at mossy fiber\u2014CA3 synapses after status epilepticus","volume":"93","author":"Chang","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1124\/jpet.114.218768_bib13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1528-1157.1980.tb04315.x","article-title":"Epilepsy and neuron loss in the hippocampus","volume":"21","author":"Dam","year":"1980","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.114.218768_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jn\/36.1.139","article-title":"The relation between starvation, metabolic acidosis and convulsive seizures in rats","volume":"36","author":"Davenport","year":"1948","journal-title":"J Nutr"},{"key":"10.1124\/jpet.114.218768_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neulet.2008.01.032","article-title":"Effects of short-term and long-term treatment with medium- and long-chain triglycerides ketogenic diet on cortical spreading depression in young rats","volume":"434","author":"De Almeida Rabello","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.114.218768_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0006-8993(89)90234-5","article-title":"Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy","volume":"495","author":"De Lanerolle","year":"1989","journal-title":"Brain Res"},{"key":"10.1124\/jpet.114.218768_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pharmthera.2004.10.004","article-title":"Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy","volume":"105","author":"DeLorenzo","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.114.218768_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2008.01.025","article-title":"Time course and mechanism of hippocampal neuronal death in an in vitro model of status epilepticus: role of NMDA receptor activation and NMDA dependent calcium entry","volume":"583","author":"Deshpande","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.114.218768_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1021\/tx0502241","article-title":"Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives","volume":"19","author":"Eikel","year":"2006","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/jpet.114.218768_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0006-8993(74)90767-7","article-title":"Potassium activity in rabbit cortex","volume":"75","author":"Futamachi","year":"1974","journal-title":"Brain Res"},{"key":"10.1124\/jpet.114.218768_bib21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00008877-200609000-00009","article-title":"Neuroprotective and disease-modifying effects of the ketogenic diet","volume":"17","author":"Gasior","year":"2006","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.114.218768_bib22","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J"},{"key":"10.1124\/jpet.114.218768_bib23","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1158\/0008-5472.CAN-03-0799","article-title":"Histone deacetylase is a target of valproic acid-mediated cellular differentiation","volume":"64","author":"Gurvich","year":"2004","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.114.218768_bib24","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/clinchem\/28.4.642","article-title":"Monitoring octanoic and decanoic acids in plasma from children with intractable epilepsy treated with medium-chain triglyceride diet","volume":"28","author":"Haidukewych","year":"1982","journal-title":"Clin Chem"},{"key":"10.1124\/jpet.114.218768_bib26","first-page":"237","article-title":"Extracellular free calcium and potassium during paroxsmal activity in the cerebral cortex of the cat","volume":"27","author":"Heinemann","year":"1977","journal-title":"Exp Brain Res"},{"key":"10.1124\/jpet.114.218768_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1743-7075-6-31","article-title":"Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer\u2019s disease: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"6","author":"Henderson","year":"2009","journal-title":"Nutr Metab (Lond)"},{"key":"10.1124\/jpet.114.218768_bib28","doi-asserted-by":"crossref","unstructured":"Hori N, Katsuda N (1974) Proceedings: Neuropharmacological study on the \u201cdepolarization shift\u201d generation in hippocampal pyramidal cells in vitro. Jpn J Pharmacol 24;S:111.","DOI":"10.1016\/S0021-5198(19)32316-9"},{"key":"10.1124\/jpet.114.218768_bib29","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1212\/WNL.21.11.1097","article-title":"Medium-chain triglycerides as a therapy for intractable childhood epilepsy","volume":"21","author":"Huttenlocher","year":"1971","journal-title":"Neurology"},{"key":"10.1124\/jpet.114.218768_bib30","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa0907328","article-title":"Valproic acid monotherapy in pregnancy and major congenital malformations","volume":"362","author":"Jentink","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.114.218768_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0165-0270(87)90041-0","article-title":"Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay","volume":"20","author":"Koh","year":"1987","journal-title":"J Neurosci Methods"},{"key":"10.1124\/jpet.114.218768_bib32","first-page":"441","article-title":"Major malformations with valproic acid","volume":"52","author":"Koren","year":"2006","journal-title":"Can Fam Physician"},{"key":"10.1124\/jpet.114.218768_bib33","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.nurt.2009.01.005","article-title":"Ketogenic diets: evidence for short- and long-term efficacy","volume":"6","author":"Kossoff","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1124\/jpet.114.218768_bib34","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0021-9258(18)76581-2","article-title":"On Walden inversion: XVI. The influence of substituting groups on optical rotation in the series of disubstituted propionic acids containing an ethyl group","volume":"91","author":"Levene","year":"1931","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.114.218768_bib35","series-title":"Antiepileptic Drugs, Pharmacology and Therapeutics","first-page":"19","article-title":"Animal models of epilepsy and epileptic seizures","author":"Loscher","year":"1999"},{"key":"10.1124\/jpet.114.218768_bib36","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.seizure.2011.01.003","article-title":"Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs","volume":"20","author":"L\u00f6scher","year":"2011","journal-title":"Seizure"},{"key":"10.1124\/jpet.114.218768_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0006-8993(94)91050-2","article-title":"Closely spaced recurrent hippocampal seizures elicit two types of heightened epileptogenesis: a rapidly developing, transient kindling and a slowly developing, enduring kindling","volume":"649","author":"Lothman","year":"1994","journal-title":"Brain Res"},{"key":"10.1124\/jpet.114.218768_bib38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0014-4886(74)90023-5","article-title":"Extracellular potassium activity during epileptogenesis","volume":"42","author":"Moody","year":"1974","journal-title":"Exp Neurol"},{"key":"10.1124\/jpet.114.218768_bib39","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1474-4422(08)70092-9","article-title":"The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial","volume":"7","author":"Neal","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1124\/jpet.114.218768_bib40","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1528-1167.2008.01870.x","article-title":"A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy","volume":"50","author":"Neal","year":"2009","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.114.218768_bib41","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1124\/jpet.114.218768_bib42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0022-3565(25)27209-3","article-title":"The influence of aging on the activity of anticonvulsant drugs","volume":"150","author":"Petty","year":"1965","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.114.218768_bib43","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.114.218768_bib44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1528-1157.1985.tb05401.x","article-title":"Potassium, pentylenetetrazol, and anticonvulsants in mouse hippocampal slices","volume":"26","author":"Piredda","year":"1985","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.114.218768_bib45","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation. II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1124\/jpet.114.218768_bib46","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0197-4580(03)00087-3","article-title":"Effects of beta-hydroxybutyrate on cognition in memory-impaired adults","volume":"25","author":"Reger","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.1124\/jpet.114.218768_bib47","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0006-8993(02)03371-1","article-title":"Cysteamine pre-treatment reduces pentylenetetrazol-induced plasticity and epileptiform discharge in the CA1 region of rat hippocampal slices","volume":"955","author":"Rostampour","year":"2002","journal-title":"Brain Res"},{"key":"10.1124\/jpet.114.218768_bib48","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.eplepsyres.2010.09.002","article-title":"Comparative anticonvulsant efficacy in the corneal kindled mouse model of partial epilepsy: Correlation with other seizure and epilepsy models","volume":"92","author":"Rowley","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1124\/jpet.114.218768_bib49","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/adc.61.12.1168","article-title":"The medium chain triglyceride diet and intractable epilepsy","volume":"61","author":"Sills","year":"1986","journal-title":"Arch Dis Child"},{"key":"10.1124\/jpet.114.218768_bib50","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fphar.2012.00059","article-title":"The ketogenic diet as a treatment paradigm for diverse neurological disorders","volume":"3","author":"Stafstrom","year":"2012","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.114.218768_bib51","series-title":"Antiepileptic Drugs","first-page":"85","article-title":"General principles: experimental selection, quantification, and evalulation of anticonvulsants","author":"Swinyard","year":"1995"},{"key":"10.1124\/jpet.114.218768_bib53","first-page":"96","article-title":"The search for new drugs against epilepsy","volume":"10","author":"Toman","year":"1952","journal-title":"Tex Rep Biol Med"},{"key":"10.1124\/jpet.114.218768_bib54","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1212\/01.WNL.0000152046.11390.45","article-title":"Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study","volume":"64","author":"VanItallie","year":"2005","journal-title":"Neurology"},{"key":"10.1124\/jpet.114.218768_bib55","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archneur.55.11.1433","article-title":"A multicenter study of the efficacy of the ketogenic diet","volume":"55","author":"Vining","year":"1998","journal-title":"Arch Neurol"},{"issue":"Suppl 7","key":"10.1124\/jpet.114.218768_bib56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1528-1157.44.s7.10.x","article-title":"Preclinical development of antiepileptic drugs: past, present, and future directions","volume":"44","author":"White","year":"2003","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.114.218768_bib57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0074-7742(06)81006-8","article-title":"Mechanisms of action of antiepileptic drugs","volume":"81","author":"White","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"10.1124\/jpet.114.218768_bib58","series-title":"Antiepileptic Drugs","first-page":"99","article-title":"General principles; experimental selection, quantification and evaluation of antiepileptic drugs","author":"White","year":"1995"},{"key":"10.1124\/jpet.114.218768_bib59","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.neuropharm.2011.12.015","article-title":"Anticonvulsant profile of caprylic acid, a main constituent of the medium-chain triglyceride (MCT) ketogenic diet, in mice","volume":"62","author":"Wla\u017a","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.114.218768_bib60","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/190515a0","article-title":"Sex and strain differences in electroshock convulsions of the rat","volume":"190","author":"Woolley","year":"1961","journal-title":"Nature"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524189021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524189021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.114.218768","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:56:17Z","timestamp":1739987777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524189021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0022356524189021"],"URL":"https:\/\/doi.org\/10.1124\/jpet.114.218768","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seizure Control by Derivatives of Medium Chain Fatty Acids Associated with the Ketogenic Diet Show Novel Branching-Point Structure for Enhanced Potency","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.114.218768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}